Table 3 Prevalence of metabolic syndrome and metabolic score among Ghanaian pre-and postmenopausal women
Parameters | Total | Postmenopausal | Premenopausal | P value |
|---|---|---|---|---|
(n = 250) | (n = 107) | (n = 143) | ||
Prevalence of metabolic syndrome | ||||
WHO | 36(14.4%) | 27(25.2%) | 9(6.3%) | <0.0001 |
NCEP-ATP III | 65(26.0%) | 44(41.1%) | 21(14.7%) | <0.0001 |
IDF | 73(29.2%) | 46(43.0%) | 27(18.9%) | <0.0001 |
H_MS | 76(30.4%) | 47(43.9%) | 29(20.3%) | <0.0001 |
Prevalence of clustering of one or two or more components of metabolic syndrome | ||||
WHO | ||||
0 | 34(13.6%) | 1(1.0%) | 33(23.1%) | <0.0001 |
1 | 70(28.0%) | 20(18.7%) | 50(35.0%) | 0.0050 |
2 | 76(30.4%) | 45(42.1%) | 31(21.7%) | 0.0010 |
>2 without MetS | 34(13.6%) | 14(13.1%) | 20(14.0%) | 1.0000 |
NCEP-ATP III | ||||
0 | 30(12.0%) | 3(2.8%) | 27(18.9%) | <0.0001 |
1 | 57(22.8%) | 13(12.1%) | 44(30.8%) | 0.0010 |
2 | 98(39.2) | 47(43.9%) | 51(35.7%) | 0.1930 |
IDF | ||||
0 | 13(5.2%) | 0(0.0%) | 13(9.1%) | 0.0010 |
1 | 50(20.0%) | 8(7.5%) | 42(29.4%) | <0.0001 |
2 | 111(44.4%) | 52(48.6%) | 59(41.3%) | 0.3030 |
>2 without MetS | 3(1.2%) | 1(1.0%) | 2(1.4%) | 1.0000 |
H_MS | ||||
0 | 13(5.2%) | 0(0.0%) | 13(9.1%) | 0.0010 |
1 | 50(20.0%) | 8(7.5%) | 42(29.4%) | <0.0001 |
2 | 111(44.4%) | 52(48.6%) | 59(41.3%) | 0.3030 |